Thomas Courant
L.A.C. (Switzerland)(CH)Institut de Recherche Vaccinale(FR)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Nanoparticle-Based Drug Delivery, Immunotherapy and Immune Responses, RNA Interference and Gene Delivery, Advanced MRI Techniques and Applications
Most-Cited Works
- → Hydrogels Incorporating GdDOTA: Towards Highly Efficient Dual T1/T2 MRI Contrast Agents(2012)158 cited
- → Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice(2021)99 cited
- → Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates(2018)59 cited
- → Larger or more? Nanoparticle characterisation methods for recognition of dimers(2017)52 cited
- → Tailoring nanostructured lipid carriers for the delivery of protein antigens: Physicochemical properties versus immunogenicity studies(2017)51 cited
- → Biodegradable Ionic Liquids: Selected Synthetic Applications(2007)36 cited
- → OVX033, a nucleocapsid-based vaccine candidate, provides broad-spectrum protection against SARS-CoV-2 variants in a hamster challenge model(2023)32 cited
- → Characterization of Collagen/Lipid Nanoparticle–Curcumin Cryostructurates for Wound Healing Applications(2019)31 cited
- → Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamsters(2021)19 cited
- → Development and physicochemical characterization of copper complexes-loaded PLGA nanoparticles(2009)16 cited